The Kinetic Characteristics of Malic Enzyme in Human Breast Tissue Cancer Cell Lines MCF-7 and MDA-MB-231

Journal Title: Middle East Journal of Cancer - Year 2019, Vol 10, Issue 2

Abstract

Background: A high level of replication is one of the main indicators of tumors. Tumor cells have to manufacture and transport macromolecules into daughter cells. One of the required enzymes is malic enzyme, which generates the NADPH for fatty acid synthesis in order to make cell membrane and pyruvate, and support the glycolysis pathway to supply the energy demand. Due to the enormous proliferation of cancer cells, it is likely that the activity of malic enzyme in cancer cells is more than normal cells. The aim of this study is to survey the kinetics of malic enzyme in tumor and normal breast tissues. Methods: We obtained the tumor and normal breast tissue specimens directly from the operating room. The assays were performed with partially purified samples under optimum conditions for the substrate and co-factor requirements. The velocity of the enzyme or Michaelis-Menten constant, maximum velocity, and the amount of inhibitor that reduced the enzyme activity by 50% were obtained and calculated in all samples. Results: The Michaelis-Menten constant for malate was lower in tumors compared to normal samples. In contrast, the maximum velocity for malate in tumors was higher than normal tissues, whereas the amount of inhibitor that reduced the enzyme activity by 50% of guanidine hydrochloride and sodium chloride were both higher in tumors than normal tissues. Conclusion: The obtained results indicated that the malic enzyme kinetics had different patterns in tumor tissues in comparison with normal tissues. A higher affinity of malic enzyme for pyruvate production in tumors supported high aerobic glycolysis. Moreover, it could be an approach to connect glutaminolysis to the glycolysis pathway. Malic enzyme could be a target to inhibit the glycolysis and glutaminolysis pathways in tumors.

Authors and Affiliations

Mahshid Bagherzadeh Ansari, Ali Shahriari, Abdolhossein Talaeizadeh, Payam Fathizadeh

Keywords

Related Articles

Association of Glutathione S-transferase Genes (M1 and T1) with the Risk of Acute Myeloid Leukemia in a Moroccan Population

Background: Acute myeloid leukemia, as most cancers, results from exposure to carcinogens and an impaired inherited individual capacity to eliminate xenobiotics. The present case-control study measures the relationship b...

Prognostic Factors of Anaplastic Thyroid Carcinoma: An Egyptian Single Institution Experience

Background: Anaplastic thyroid carcinoma is an extremely aggressive cancer that has a very poor outcome. We have analyzed predictive factors for overall survival and different therapeutic modalities that could help to de...

Patients’ Experiences with the Degenerative Process of Cancer: A Content-analysis Study in Iran

Background: This study sought to provide a comprehensive understanding of cancer treatment refusal based on the experiences of patients, caregivers, and health care providers. Methods: In this qualitative research study,...

Clustering of Breast Cancer Cases among Women from Kurdistan Province, Iran: A Population-based Cross-sectional Study

Background: Spatial analysis is one of the required tools of epidemiology and public health sciences. This study intends to detect significant clusters of breast cancer cases in Kurdistan Province, Iran. Methods: We obt...

Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro

Background: IMOD™, a selenium enriched extract of the plants Tanacetum vulgare, Urtica dioica, and Rosa canina, has an excellent effect on oxidative stress. In this study, we investigated the radioprotective effects of t...

Download PDF file
  • EP ID EP638850
  • DOI 10.30476/mejc.2019.78500
  • Views 77
  • Downloads 0

How To Cite

Mahshid Bagherzadeh Ansari, Ali Shahriari, Abdolhossein Talaeizadeh, Payam Fathizadeh (2019). The Kinetic Characteristics of Malic Enzyme in Human Breast Tissue Cancer Cell Lines MCF-7 and MDA-MB-231. Middle East Journal of Cancer, 10(2), 78-86. https://europub.co.uk/articles/-A-638850